| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/08/2006 | WO2006093352A1 Compound having cyclic structure and use thereof |
| 09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093337A1 Preventive/therapeutic agent for cancer |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093329A1 Antimicrobial agent |
| 09/08/2006 | WO2006093291A1 19-norvitamin d derivative |
| 09/08/2006 | WO2006093290A1 9-substituted-19-norvitamin d derivative |
| 09/08/2006 | WO2006093253A1 Novel cyclic compound having quinolylalkylthio group |
| 09/08/2006 | WO2006093251A1 Novel photosensitizer |
| 09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
| 09/08/2006 | WO2006093226A1 Antipruritic agent |
| 09/08/2006 | WO2006093217A1 Composition promoting calcium absorption and utilization of the same |
| 09/08/2006 | WO2006093211A1 Anti-viral agent |
| 09/08/2006 | WO2006093202A1 Phloroacylphenone glycoside, process for production of the same, antiallergic agent and antioxidant |
| 09/08/2006 | WO2006093194A1 Antiallergic composition |
| 09/08/2006 | WO2006093192A1 Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia |
| 09/08/2006 | WO2006093175A1 High-molecular fucoidan, method of producing the same and cosmetic composition |
| 09/08/2006 | WO2006093157A1 Oligonucleotide derivative, probe for detection of gene, and dna chip |
| 09/08/2006 | WO2006093139A1 Transdermally absorbable preparation |
| 09/08/2006 | WO2006093124A1 Free radical scavenger containing semicarbazide derivative |
| 09/08/2006 | WO2006093118A1 Drug and food composition for enhancing immune responce containing at oligonucleotide as the active ingredient |
| 09/08/2006 | WO2006093114A1 Method of producing chlorogenic acid composition |
| 09/08/2006 | WO2006093110A1 Nitroguanosine-3’,5’-cyclic monophosphate and protein kinase g activator |
| 09/08/2006 | WO2006093041A1 Novel crystals of n-benzyl-n-ethyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9h-purin-9-yl)acetoamide |
| 09/08/2006 | WO2006093034A1 Mental disorder-related gene and use of the same |
| 09/08/2006 | WO2006093014A1 Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same |
| 09/08/2006 | WO2006092992A1 Prophylactic antistress agent |
| 09/08/2006 | WO2006092893A1 Enterokinesis promoting compound |
| 09/08/2006 | WO2006092829A1 External plaster containing flurbiprofen |
| 09/08/2006 | WO2006092822A2 4-fluorophenyl-derivatives of 1-{[1,5 -bis (4-chloro phenyl) -2-methyl-1h-pyrrol-3-yl]methyl} -4- methylpi pεrazine, synthesis process and uses thereof |
| 09/08/2006 | WO2006092809A1 PROCESS FOR PRODUCING POLYMORPH FORM (I) OF l-BENZYL-4- [(5, 6-DIMETHOXY-l-INDANONE) -2YL] METHYL PIPERIDINE HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE) |
| 09/08/2006 | WO2006092741A2 Treatment of inflammatory disorders with praziquantel |
| 09/08/2006 | WO2006092739A1 Anti-inflammatory conjugates of macrolides and coumarins |
| 09/08/2006 | WO2006092731A1 1, 2, 4-triazole derivatives and their use as oxytocin antagonists |
| 09/08/2006 | WO2006092714A2 Inhibition of spag9 expression with sirnas |
| 09/08/2006 | WO2006092710A1 Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione |
| 09/08/2006 | WO2006092692A1 Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain |
| 09/08/2006 | WO2006092691A1 Use of pde7 inhibitors for the treatment of neuropathic pain |
| 09/08/2006 | WO2006092623A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 09/08/2006 | WO2006092622A1 Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl patty acid glycerol monoesters |
| 09/08/2006 | WO2006092619A1 Methods and pharmaceutical compositions for the treatment of neurological damage |
| 09/08/2006 | WO2006092617A1 Crystallisation and purification of glycopyrronium bromide |
| 09/08/2006 | WO2006092608A1 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity |
| 09/08/2006 | WO2006092599A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 09/08/2006 | WO2006092581A1 Lubricating composition |
| 09/08/2006 | WO2006092580A1 Combination therapy |
| 09/08/2006 | WO2006092579A1 Microcrystalline ( 5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid |
| 09/08/2006 | WO2006092574A1 Indolylamino quinazoline derivatives as antitumor agents |
| 09/08/2006 | WO2006092573A1 Indazolylamino qionazoline derivatives as antitumor agents |
| 09/08/2006 | WO2006092569A1 Production process for nsaid-containing lozenges, their compositions, their medicinal use |
| 09/08/2006 | WO2006092510A1 Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use |
| 09/08/2006 | WO2006092507A1 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
| 09/08/2006 | WO2006092495A1 Novel derivatives of phosphinic amino acids, preparation method thereof and pharmaceutical compositions containing same |
| 09/08/2006 | WO2006092494A1 $g(g)d crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 09/08/2006 | WO2006092493A1 $g(b) crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 09/08/2006 | WO2006092492A1 $g(g) crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 09/08/2006 | WO2006092491A1 $g(b)d crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 09/08/2006 | WO2006092490A1 Diosmetin derivatives for the treatment and prevention of thrombotic pathologies |
| 09/08/2006 | WO2006092430A1 Selective inhibitors of human corticosteroid synthases |
| 09/08/2006 | WO2006092422A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives |
| 09/08/2006 | WO2006092417A1 6 -heteroaryl-1, 2, 3,4,4a, 1ob-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders |
| 09/08/2006 | WO2006092395A1 9-amino-acridine derivatives and their use for eliminating misfolded proteins |
| 09/08/2006 | WO2006092374A1 Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound |
| 09/08/2006 | WO2006092334A1 Novel polymorph of mutilin |
| 09/08/2006 | WO2006092298A1 Salts, addition compounds and complex compounds of guanidinoacetic acid |
| 09/08/2006 | WO2006092295A1 Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support |
| 09/08/2006 | WO2006092294A1 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof |
| 09/08/2006 | WO2006092268A1 Bicyclic five-membered heteroaryl derivatives and their use as renin inhibitors |
| 09/08/2006 | WO2006092255A1 Pharmaceutical composition comprising an indolylmaleimide derivative |
| 09/08/2006 | WO2006092233A1 Amide derivatives of hyaluronic acid in osteoarthrosis |
| 09/08/2006 | WO2006092222A1 Medicament forms with controlled bioavailability |
| 09/08/2006 | WO2006092209A1 Novel targets and compounds useful in the treatment of a cardiovascular disorder, dyslipidemia and atherosclerosis, and methods to identify such compounds |
| 09/08/2006 | WO2006092207A1 Pharmaceutical forms with improved pharmacokinetic properties |
| 09/08/2006 | WO2006092204A1 Derivatives of aminobutanoic acid inhibiting cpt |
| 09/08/2006 | WO2006092202A1 Thienopyridine derivatives and use thereof as hsp90 modulators |
| 09/08/2006 | WO2006092151A1 Topical corticosteroid containing formulation for treatment of psoriasis, eczema, ulcer and burns |
| 09/08/2006 | WO2006092143A1 Substituted pyridine derivatives |
| 09/08/2006 | WO2006092081A1 Insulin analogs from euphorbia lunulata extracts and the use thereof and the use of interleukin-10 analogs |
| 09/08/2006 | WO2006092059A1 Design and synthesis of novel antimicrobials |
| 09/08/2006 | WO2006092049A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 09/08/2006 | WO2006092032A2 PHARMACEUTICAL COMPOSITIONS CONTAINING 1-METHYL-3,6,7,8-TETRAHYDROPIRAZOLO[3,4-b]PIRROLO[4,3-d]PYRIDINE-6,8-DIONE DERIVATIVES, USE, AND PROCESS FOR PREPARING THEM |
| 09/08/2006 | WO2006092025A1 Compounds having lipid lowering properties |
| 09/08/2006 | WO2006092024A1 Compounds having anti-cancer properties |
| 09/08/2006 | WO2006092017A1 Glycoalkaloid and tlr agonist combinations and various uses thereof |
| 09/08/2006 | WO2006080043A3 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 09/08/2006 | WO2006078986A3 Quorum sensing modulators |
| 09/08/2006 | WO2006078904A3 Use of tetrazole derivatives as quorum sensing modulators |
| 09/08/2006 | WO2006077025A3 Morpholines as 5ht2c agonists |
| 09/08/2006 | WO2006077024A3 5-aminoindole derivatives |
| 09/08/2006 | WO2006074129A3 Agents for therapy efficacy monitoring and deep tissue imaging |
| 09/08/2006 | WO2006073610A8 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 09/08/2006 | WO2006071548A3 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/08/2006 | WO2006069293A3 Composition comprising n-acetylcysteine and further pain or anti- inflamm medications |
| 09/08/2006 | WO2006069175A3 Antifungal properties of various forms of sophorolipids |
| 09/08/2006 | WO2006068713A3 3,3'-diindolylmethane immune activating compositions |
| 09/08/2006 | WO2006067414A3 Glycine transport inhibitors |
| 09/08/2006 | WO2006066074A3 Lung-targeted drugs |
| 09/08/2006 | WO2006065743A3 Tetracylic bicyclolides |
| 09/08/2006 | WO2006063841A3 Trycyclic heterocycles, their manufacture and use as pharmaceutical agents |
| 09/08/2006 | WO2006063811A3 Substituted 1,2,4-triazin-5(2h)-ones |